Beta-blockers (Ocular route only) (versus unexposed) updated on 12-17-2024

Neonatal medical care

R analysis
id Study   Lib. in paper Exposition period    Study type  Control type 
 
Tags OR 95%CI x1/n1 x0/n0 no cases no exposed ROB Ref.
S17249
R72195
Kaufman - Beta-blockers, 2024 Neonatal intensive care unit stay during pregnancy (anytime or not specified) retrospective cohort unexposed, sick Adjustment: No 0.87 [0.15;4.98] C 5/48   2/17 7 48
ref
S14054
R55588
Pellegrino - Timolol, 2018 Neonatal Respiratory complication (apnea, cyanosis, grunting, inspiratory stridor, nasal flaring, poor feeding, and tachypnea (more than 60 breaths per minute)) throughout pregnancy prospective cohort unexposed, disease free Adjustment: No 8.24 [0.50;136.65] C 1/22   1/174 2 22
ref
Total 2 studies 2.02 [0.24;17.03] 9 70
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives

Forest plot

StudyTE95% CIn casesn exposedweightROBABCDEF Kaufman - Beta-blockers, 2024Kaufman - Beta-blockers, 2024 0.87[0.15; 4.98]74863%ROB confusion: criticalROB selection: unclearROB classification: criticalROB missing: lowROB mesure: criticalROB reporting: moderate Pellegrino - Timolol, 2018Pellegrino - Timolol, 2018 8.24[0.50; 136.65]22237%ROB confusion: criticalROB selection: moderateROB classification: moderateROB missing: unclearROB mesure: criticalROB reporting: moderate Total (2 studies) I2 = 44% 2.02[0.24; 17.03]9700.220.01.0ROB: A: confusion, B: selection, C: classification, D: missing, E: measurement, F: reportinglow,moderate,serious,critical,unclear,

Sensitivity analysis

SubsetTE95% CIn casesn exposedkI2 Type of studies cohort studiescohort studies 2.02[0.24; 17.03]97044%NAKaufman - Beta-blockers, 2024 Pellegrino - Timolol, 2018 2 case control studiescase control studies 0 Type of controls unexposed (disease free or unspecified)unexposed (disease free or unspecified) 8.24[0.50; 136.65]222 -NAPellegrino - Timolol, 2018 1 unexposed, sickunexposed, sick 0.87[0.15; 4.98]748 -NAKaufman - Beta-blockers, 2024 1 Tags Adjustment   - No  - No 2.02[0.24; 17.03]97044%NAKaufman - Beta-blockers, 2024 Pellegrino - Timolol, 2018 2 All studiesAll studies 2.02[0.24; 17.03]97044%NAKaufman - Beta-blockers, 2024 Pellegrino - Timolol, 2018 20.220.01.0

Publication bias and p-hacking diagnosis

funnel plot

Funnel plot not drawn. Less than 3 points.

Asymetry test p-value = NaN (by Egger's regression)

not enought points

p values plot

Funnel plot not drawn. Less than 3 points.

Sub-groups analysis using all included studies

excluded

Sub-groupsTE95% CIn casesn exposedkI2ROB type of controls unexposed controls (disease free or unspecified)unexposed controls (disease free or unspecified) 8.24[0.50; 136.65]222 -NAPellegrino - Timolol, 2018 1 unexposed, sick controlsunexposed, sick controls 0.87[0.15; 4.98]748 -NAKaufman - Beta-blockers, 2024 10.510.01.0